SAM
GMED icon

Smartleaf Asset Management’s Globus Medical GMED Stock Holding History

Smartleaf Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$175K Sell
2,100
-54
-3% -$4.85K 0.01% 836
2025
Q4 		$189K Sell
2,154
-604
-22% -$45.8K 0.01% 824
2025
Q3 		$156K Sell
2,758
-96
-3% -$5.53K 0.01% 840
2025
Q2 		$167K Sell
2,854
-306
-10% -$19.8K 0.01% 638
2025
Q1 		$229K Sell
3,160
-850
-21% -$70.2K 0.02% 528
2024
Q4 		$332K Buy
4,010
+351
+10% +$27.7K 0.03% 417
2024
Q3 		$258K Buy
3,659
+657
+22% +$46.4K 0.03% 431
2024
Q2 		$207K Buy
3,002
+600
+25% +$35.8K 0.03% 373
2024
Q1 		$127K Buy
2,402
+32
+1% +$1.72K 0.02% 467
2023
Q4 		$128K Buy
+2,370
New +$116K 0.03% 386

Other funds holding GMED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return